Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020

0Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Introduction The coronavirus disease 2019 (COVID-19) pandemic could disproportionately affect individuals who have a substance use disorder (SUD). However, little information exists on COVID-19-related experiences among individuals with a SUD. We examined whether individuals with a SUD differ from other individuals with regard to COVID-19 testing, susceptibility, and employment-related vulnerability. Methods We used data from a U.S. nationally representative survey (n = 1,208). Using logistic regressions, we examined whether individuals with SUDs differ from other individuals regarding underlying health conditions, COVID-19 testing, access to paid sick leave, and loss of employment. Data were collected in late May-early June, 2020. Results Four percent of participants reported that a healthcare professional had told them they had a SUD. We found that, compared to those without SUDs, respondents with SUDs had higher odds of having lost their job due to the pandemic (adjusted odds ratio [AOR]:5.17, 95% confidence interval [CI]:2.28–11.74). Among individuals who were employed prior to the pandemic, people with SUDs had lower odds of having paid sick leave (AOR:0.26, 95% CI:0.09–0.74). Conclusion Our study indicates that individuals with SUDs could be disproportionately affected by COVID-19 economically, which might worsen SUD and racial/ethnic health disparities. Introduction There is growing concern about the impact of the coronavirus (COVID-19) pandemic on the health of individuals who have a substance use disorder (SUD) [1]. Individuals with a SUD might also be disproportionately affected by the rise in pandemic-related unemployment [2] since some industries that were highly impacted by the shutdowns, such as food service, are more common among those who report illicit substance use [3]. Despite these concerns, very little data exist on COVID-19 testing and pandemic-related challenges among individuals with a SUD [4, 5]. In the current study, we surveyed a nationally representative sample of adults in the United States (U.S.) in the early stages of the pandemic to explore differences between individuals with and without a SUD with regard to: underlying health conditions that exacerbate COVID-19 morbidity, COVID-19 testing, available paid sick leave, and loss of employment.

Cite

CITATION STYLE

APA

Acevedo, A., Feng, W., Corlin, L., Allen, J. D., Levine, P., & Stopka, T. J. (2022). Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020. PLoS ONE, 17(7 July). https://doi.org/10.1371/journal.pone.0271788

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free